1789 — ScinoPharm Taiwan Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapFalling Star

Annual balance sheet for ScinoPharm Taiwan, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,089	4,132	4,346	3,942	4,166
Net Total Accounts Receivable
Net Total Receivables	473	393	654	813	654
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,916	5,967	6,320	6,381	6,608
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,975	4,883	4,797	4,578	4,576
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	11,847	11,691	11,911	11,722	11,943
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	687	556	803	729	768
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,317	1,180	1,461	1,357	1,417
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	10,529	10,511	10,450	10,364	10,526
Total Liabilities & Shareholders' Equity	11,847	11,691	11,911	11,722	11,943
Total Common Shares Outstanding